Cancer Immunotherapy is an advanced paradigm in cancer therapeutics. Cancer immunotherapy works by enhancing the patient’s immune system. This is generally accompanied by the administration of synthesized immune proteins.
The most common therapeutic areas of cancer immunotherapy are inclusive of breast, prostate, lung cancer, and others. Increasing prevalence of the cancer is one of the major drivers for the market growth during the forecast period.
According to the National Cancer Institute in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. and approximately 595,690 people died due to cancer within the region.
Moreover, it was estimated that the national healthcare expenditures for cancer care in the U.S. totalled nearly to USD 125 billion in 2010, and it is expected to reach USD 156 billion by 2020.
For Exclusive Sample Copy Visit @ https://www.marketresearchfuture.com/sample_request/592
Market Key Players
- Amgen Inc. (U.S.)
- AstraZeneca (U.K)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (U.S.)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
The Americas cancer immunotherapy market is expected to grow at an approximate CAGR of 10.1% during the forecast period.
The Americas cancer immunotherapy market is segmented on the basis of cancer, therapeutics, and end users. On the basis of the cancer, the market is segmented into lung cancer, prostate cancer, colorectal cancer, head & neck cancer, and others.
For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/cancer-immunotherapy-market-592
On the basis of the therapeutics, the market is segmented into monoclonal antibodies, immune checkpoint inhibitors, vaccines, non-specific cancer immunotherapies and adjuvants, and others.
The naked monoclonal antibodies segment, by monoclonal antibody segment, is father segmented into alemtuzumab, trastuzumab, and others.
Market Regional Analysis
On regional basis the Americas is divided into North America and Latin America. North America is sub segmented into U.S. and Canada. North America commands for the largest market share for the Americas cancer immunotherapy market due the presence of the U.S. within the region.
This large share is also attributed due to the technologically advanced healthcare market in the region which is followed by high prevalence of cancer, increasing development in cancer immunotherapy treatment and rising per capita healthcare expenditure.
The total number of the biotechnology industries in the U.S. increased from 2,763 in 2014 and reached 2,772 in 2015. Additionally, the abundance of state of the art laboratories in the U.S. is also facilitating the market growth.
Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/592
Major Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Cancer Immunotherapy Market, By Type
Chapter 7. Global Cancer Immunotherapy Market, By Treatment
Chapter 8 Global Cancer Immunotherapy Market, By End User
Chapter 9. Global Cancer Immunotherapy Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar